| Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study C Garcia-Vidal, G Sanjuan, E Moreno-García, P Puerta-Alcalde, ... Clinical Microbiology and Infection 27 (1), 83-88, 2021 | 1042 | 2021 |
| Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia A Soriano, F Marco, JA Martínez, E Pisos, M Almela, VP Dimova, D Alamo, ... Clinical Infectious Diseases 46 (2), 193-200, 2008 | 977 | 2008 |
| Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double‐blind, placebo‐controlled trial P Ginés, A Rimola, R Planas, V Vargas, F Marco, M Almela, M Forne, ... Hepatology 12 (4), 716-724, 1990 | 808 | 1990 |
| Addition of a macrolide to a β-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia JA Martínez, JP Horcajada, M Almela, F Marco, A Soriano, MA Marco, ... Clinical Infectious Diseases 36 (4), 389-395, 2003 | 566 | 2003 |
| Severe community-acquired pneumonia: risk factors and follow-up epidemiology M Ruiz, S Ewig, A Torres, F Arancibia, F Marco, J Mensa, M Sanchez, ... American journal of respiratory and critical care medicine 160 (3), 923-929, 1999 | 470 | 1999 |
| Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis M Navasa, A Follo, JM Llovet, G Clemente, V Vargas, A Rimola, F Marco, ... Gastroenterology 111 (4), 1011-1017, 1996 | 392 | 1996 |
| Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment: analysis of 189 episodes F Vidal, J Mensa, M Almela, JA Martínez, F Marco, C Casals, JM Gatell, ... Archives of internal medicine 156 (18), 2121-2126, 1996 | 371 | 1996 |
| Pathogenic Significance of Methicillin Resistance for Patients with Staphylococcus aureus Bacteremia A Soriano, JA Martinez, J Mensa, F Marco, M Almela, A Moreno-Martinez, ... Clinical infectious diseases 30 (2), 368-373, 2000 | 331 | 2000 |
| Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs J Vila, J Ruiz, F Marco, A Barcelo, P Goni, E Giralt, T Jimenez de Anta Antimicrobial agents and chemotherapy 38 (10), 2477-2479, 1994 | 316 | 1994 |
| In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi MA Pfaller, F Marco, SA Messer, RN Jones Diagnostic microbiology and infectious disease 30 (4), 251-255, 1998 | 302 | 1998 |
| Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study A Rimola, JM Salmerón, G Clemente, L Rodrigo, A Obrador, LM Miranda, ... Hepatology 21 (3), 674-679, 1995 | 263 | 1995 |
| Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome M Ortega, F Marco, A Soriano, M Almela, JA Martínez, A Munoz, J Mensa Journal of antimicrobial chemotherapy 63 (3), 568-574, 2009 | 259 | 2009 |
| Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae S Ewig, M Ruiz, A Torres, F Marco, JA Martinez, M Sanchez, J Mensa American journal of respiratory and critical care medicine 159 (6), 1835-1842, 1999 | 256 | 1999 |
| Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone J Gavalda, O Len, JM Miró, P Munoz, M Montejo, A Alarcón, ... Annals of internal medicine 146 (8), 574-579, 2007 | 245 | 2007 |
| Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles I Anguera, A Del Río, JM Miró, X Matinez-Lacasa, F Marco, JR Gumá, ... Heart 91 (2), e10-e10, 2005 | 243 | 2005 |
| Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis VH Chu, CW Woods, JM Miro, B Hoen, CH Cabell, PA Pappas, ... Clinical infectious diseases 46 (2), 232-242, 2008 | 237 | 2008 |
| HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort ST Chambers, D Murdoch, A Morris, D Holland, P Pappas, M Almela, ... PloS one 8 (5), e63181, 2013 | 228 | 2013 |
| In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of … J Vila, A Marcos, F Marco, S Abdalla, Y Vergara, R Reig, R Gomez-Lus, ... Antimicrobial agents and chemotherapy 37 (1), 138-141, 1993 | 227 | 1993 |
| Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey J Pemán, E Cantón, G Quindós, E Eraso, J Alcoba, J Guinea, P Merino, ... Journal of Antimicrobial Chemotherapy 67 (5), 1181-1187, 2012 | 204 | 2012 |
| Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008 M Ortega, F Marco, A Soriano, M Almela, JA Martínez, J López, C Pitart, ... Journal of hospital infection 77 (2), 157-161, 2011 | 201 | 2011 |
